InvestorsHub Logo
Followers 94
Posts 2734
Boards Moderated 0
Alias Born 09/15/2020

Re: None

Friday, 08/18/2023 9:32:12 PM

Friday, August 18, 2023 9:32:12 PM

Post# of 689401
Someone mentioned that NWBO still have 9 Million series C shares, not yet sold. That's 225 million shares. The same person said that the company could use them for an equity partner. Nobody is talking about an acquisition of Oncovir, the maker of Hiltonol, which everyone seems certain will be administered with DCVax-L in all future vaccines. Not sure what the revenue/value of Oncovir is currently, but I haven't heard any talk about how we build that business relationship. Maybe NWBO is keeping quiet in order not to create a bidding war, like it looks like Merck is doing with NWBO/DCVax-L. In both cases, I am sure that people know and NWBO could be waiting for the value of the series C shares reached a value that would be high enough to use them to acquire Oncovir.

Just a thought.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News